The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (February 2020) |
Pharmaceutical manufacturer Deva Holding A.S. is a Turkish Fortune 500 company with annual revenue of more than US$250 million and a staff of approximately 2,300 across its operations in Turkey, Germany, USA and New Zealand.[1][2][3]
 | |
| Company type | Pharmaceutical Company |
|---|---|
| BİST: DEVA | |
| Industry | Healthcare |
| Founded | September 22, 1958 |
| Headquarters | Istanbul, Turkey |
Key people | Mr. Philipp Haas (Chairman and CEO) |
| Products | Pharmaceuticals |
| Revenue | US$250M |
Number of employees | 2,300 |
| Website | www.deva.com.tr |
Background edit
Established in 1958, Deva Holding A.S. is Turkey’s second largest pharmaceutical company and is primarily engaged in the production and distribution of pharmaceutical and veterinary products.[4][5]
References edit
- ^ "Antibiotic Long Distance Run". Fortune Magazine. 19 July 2019. Archived from the original on 2019-09-05. Retrieved 15 September 2019.
- ^ "5 Minutes Interview with: Philipp Haas - Deva". Pharma Horizon Magazine. 4 May 2017. Archived from the original on 2019-10-28. Retrieved 15 September 2019.
- ^ "Philipp Haas – Chairman & CEO, DEVA, Turkey". Pharma Boardroom Magazine. 29 November 2018. Archived from the original on 2019-10-28. Retrieved 15 September 2019.
- ^ "» 5 minutes interview with: Philipp Haas – DEVA". TKS Publisher. Retrieved 2019-10-28.
- ^ "DEVA.IS - Deva Holding AS Profile | Reuters". www.reuters.com. Retrieved 2019-10-28.
External links edit
 | This Turkish corporation or company article is a stub. You can help Wikipedia by expanding it. |